A1 Refereed original research article in a scientific journal

Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3




AuthorsHongisto V, Smeds N, Brecht S, Herdegen T, Courtney MJ, Coffey ET

PublisherAMER SOC MICROBIOLOGY

Publication year2003

JournalMolecular and Cellular Biology

Journal name in sourceMOLECULAR AND CELLULAR BIOLOGY

Journal acronymMOL CELL BIOL

Volume23

Issue17

First page 6027

Last page6036

Number of pages10

ISSN0270-7306

DOIhttps://doi.org/10.1128/MCB.23.17.6027-6036.2003


Abstract
Lithium has been used as an effective mood-stabilizing drug for the treatment of manic episodes and depression for 50 years. More recently, lithium has been found to protect neurons from death induced by a wide array of neurotoxic insults. However, the molecular basis for the prophylactic effects of lithium have remained obscure. A target of lithium, glycogen synthase kinase 3 (GSK-3), is implicated in neuronal death after trophic deprivation. The mechanism whereby GSK-3 exerts its neurotoxic effects is also unknown. Here we show that lithium blocks the canonical c-Jun apoptotic pathway in cerebellar granule neurons deprived of trophic support. This effect is mimicked by the structurally independent inhibitors of GSK-3, FRAT1, and indirubin. Like lithium, these prevent the stress induced c-Jun protein increase and subsequent apoptosis. These events are downstream of c-Jun transactivation, since GSK-3 inhibitors block neuronal death induced by constitutively active c-Jun (Ser/Thr-->Asp) and FRAT1 expression inhibits AP1 reporter activity. Consistent with this, AP1-dependent expression of proapoptotic Bim requires GSK-3-like activity. These data suggest that a GSK-3-like kinase acts in tandem with c-Jun N-terminal kinase to coordinate the full execution of the c-Jun stress response and neuronal death in response to trophic deprivation.



Last updated on 2024-26-11 at 20:07